Skip to main content
MedPathMedPath Home
Clinical Trials/PER-095-12
PER-095-12
Unknown
未知

HIV TESTING AND TREATMENT TO PREVENT ONWARD HIV TRANSMISSION AMONG FOR MEN WHO HAVE SEX WITH MEN AND TRANSGENDER WOMEN IN LIMA, PER

Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,0 sites0 target enrollmentFebruary 14, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 14, 2013
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,

Eligibility Criteria

Inclusion Criteria

  • •1\. MALE SEX (AT BIRTH).
  • •2\. EIGHTEEN YEARS OF AGE OR OLDER.
  • •3\. UNAWARE OF THEIR HIV STATUS.
  • •4\. ABILITY AND WILLINGNESS TO PROVIDE INFORMED CONSENT FOR STUDY PARTICIPATION, INCLUDING BEING TESTED FOR HIV\-1; FOR RE\-TESTING IF HIV NEGATIVE (STEP 2\); AND TO CONSIDER ENROLLMENT IN AN IMMEDIATE VS. DEFERRED ART TRIAL (STEP 3\) IF DIAGNOSED WITH ACUTE OR RECENT HIV INFECTION AFTER TESTING. PEOPLE DIAGNOSED WITH HIV INFECTION DURING PARTICIPATION IN STEP 2 WILL BE OFFERED ENROLLMENT IN STEP 3\.
  • •5\. WILLINGNESS TO BE RE\-CONTACTED IF HIV SERONEGATIVE BUT WITH VIROLOGIC EVIDENCE OF ACUTE INFECTION (HIV\-1 RNA POSITIVE) FOR FURTHER HIV TESTING AND LINKAGE TO CARE;
  • •6\. EVIDENCE OF HIGH RISK FOR ACQUIRING HIV\-1 INFECTION, INCLUDING ANY ONE OF THE FOLLOWING:
  • •A. SEXUAL BEHAVIORS:
  • •I. INCONSISTENT CONDOM USE DURING ANAL INTERCOURSE DURING THE LAST 6 MONTHS;
  • •II. ANAL INTERCOURSE WITH MORE THAN 5 MALE SEX PARTNERS DURING THE LAST 6 MONTHS;
  • •III. EXCHANGE OF MONEY, GIFTS, SHELTER, OR DRUGS FOR ANAL SEX WITH A MALE PARTNER DURING THE LAST 6 MONTHS;

Exclusion Criteria

  • •1\. ANY MEDICAL, PSYCHOLOGICAL/PSYCHIATRIC, OCCUPATIONAL, OR OTHER CONDITION THAT, IN THE JUDGMENT OF THE INVESTIGATOR, WOULD INTERFERE WITH, OR SERVE AS A CONTRAINDICATION TO, PROTOCOL ADHERENCE, ASSESSMENT OF SAFETY, OR A PARTICIPANT´S ABILITY TO GIVE INFORMED CONSENT;
  • •2\. SEEKING HIV TEST BEHAVIOR FOR ROUTINE REASONS.
  • •1\. ANY MEDICAL, PSYCHOLOGICAL/PSYCHIATRIC, OCCUPATIONAL, OR OTHER CONDITION THAT, IN THE JUDGMENT OF THE INVESTIGATOR, WOULD INTERFERE WITH, OR SERVE AS A CONTRAINDICATION TO, PROTOCOL ADHERENCE, ASSESSMENT OF SAFETY, OR A PARTICIPANT´S ABILITY TO GIVE INFORMED CONSENT;
  • •2\. SEEKING HIV TEST BEHAVIOR FOR ROUTINE REASONS.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
PROJECT ¿SABES?”
PER-066-14Centro de Investigacion del Cancer Fred Hutchinson, Estados Unidos,2,138
Completed
Not Applicable
Prevention of late presentation of an HIV infectioHIV prevalentieHIV prevalence
NL-OMON22242Prof.dr. A. Verbon, Dr. TEMS de Vries-Sluijs, Dhr. G.P.M. Luiken; Erasmus MC, RotterdamProf.dr. J.M. Prins; AMC, AmterdamDr. J.G. den Hollander; Maasstad zh, Rotterdam4,500
Completed
Not Applicable
Prevention of late presentation of an HIV infectioAIDSHIV10047438
NL-OMON40685Erasmus MC, Universitair Medisch Centrum Rotterdam4,000
Recruiting
Not Applicable
Sisters Antiretroviral therapy Programme for Prevention of HIV ¿ an Integrated Response (SAPPH-IRe)
PACTR201312000722390Centre for Sexual Health and HIV/AIDS Research Zimbabwe2,800
Completed
Not Applicable
CHEMOPROPHYLAXIS FOR THE PREVENTION OF HIV IN ME-Z21 Asymptomatic human immunodeficiency virus [HIV] infection statusAsymptomatic human immunodeficiency virus [HIV] infection statusZ21
PER-072-06INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS, INSTITUTOS J. DAVID GLADSTONE, FAMILY HEALTH INTERNATIONAL - FHI 360°,2,339